de la Garza, Achilles Tendon Rupture and Fluoroquinolones Use: Report of Two Cases, Arch. Med. Res., ,28, 429-30 (1997). |
Movin et al., Pathology of Achilles Tendon in Association with Ciprofloxacin Treatment, Foot & Ankle International, 18, 297-99 (1997). |
Moreira et al., Effect of Topical Fluoroquinolones on Corneal Re-Epithelialization After Excimer Laser Keratectomy, J. Cataract Refract. Surg. 23, 845-48 (1997). |
McGarvey et al., Partial Achilles Tendon Ruptures Associated with Fluoroquinolone Antibiotics: A Case Report and Literature Review, Foot & Ankle International 17, 496-98 (1996). |
Zabraniecki et al., Fluoroquinolone Induced Tendinopathy: Report of 6 Cases, J. Rheumatol. 23, 516-20 (1996). |
Szarfman et al., More on Fluoroquinolone Antibiotics and Tendon Rupture, N. Eng. J. Med., 332, 193 (1995). |
MacGowan et al., Serum Ciprofloxacin Concentrations in Patients with Severe Sepsis Being Treated with Ciprofloxacin 200 MG IV BD Irrespective of Renal Function, Journal of Antimicrobial Chemotherapy, 33, 1051-54 (1994). |
Royer et al., Features of Tendon Disorders with Fluoroquinolones, Therapie 49, 75-76 (1994). |
Shah et al., Comparative Pharmocokinetics and Safety of Ciprofloxacin 400 MG IV Thrice Daily Versus 750 MG PO Twice Daily, Journal of Antimicrobial Chemotherapy, 33, 795-801 (1994). |
Lee, J. Ciprofloxacin Associated Bilateral Achilles Tendon Rupture, Aust. N.Z. J. Med. 22, 500 (1992). |
Bergeron, The Pharmacokinetics and Tissue Penetration of the Fluoroquinolones, Clin. Invest. Med. 12, 20-27 (1989). |
Crump et al., Pharmacokinetics and Tissue Penetration of Ciprofloxacin, Antimicrob. Agents Chemother. 24, 784-86 (1983). |